Last reviewed · How we verify
BAsel Stent Kosten Effektivitäts Trial - SAphenous Venous Graft Angioplasty Using Glycoprotein IIb/IIIa Receptor Inhibitors and Drug-Eluting Stents (BASKET-SAVAGE)
Prospective multicenter controlled randomized trial to compare the safety and efficacy of drug eluting vs. bare metal stents in percutaneous coronary interventions of saphenous vein grafts. Hypothesis: Survival and outcome will be significantly better in patients receiving DES than in patients receiving BMS regarding both short-term and long-term outcome.
Details
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Phase | Phase 4 |
| Status | TERMINATED |
| Enrolment | 162 |
| Start date | 2008-02 |
| Completion | 2014-03 |
Conditions
- Coronary Artery Disease
Interventions
- Drug eluting stent
- Bare metal stent
Primary outcomes
- MACE (composite of cardiac death, i.e., all deaths not clearly non-cardiac, non-fatal myocardial infarction, and TVR — 12 months
Countries
Denmark, Germany, Switzerland